GT Biopharma, Inc., a clinical stage immuno-oncology company, announced the appointment of Manu Ohri, who joins the Company as its Chief Financial Officer (CFO) effective immediately. Ohri, an accomplished accounting and finance executive brings to GT Biopharma over 25 years of management, finance and public accounting experience in working with Board of Directors, capital markets, independent…